About Eyeject®
Our intra-ocular technology platform
Eyeject® has been designed to offer a unique minimally-invasive approach in comparison with existing implants, to administer active compounds to the back of the eye efficiently and safely. Our technology combines ease-of-administration for the practitioner as well as prolonged effect and safety for the patient.
Key features include:
- Minimally invasive and easily injectable: Eyeject® is a very fluid and easily injectable emulsion and, in constrat with implants, does not require any surgical intervention.
- A prolonged and controlled effect: Eyeject® is able to maintain therapeutic levels of active compounds in the region of the retina for long periods. The reduction of the frequency of injection also helps to preserve eye integrity.
- Safety: Eyeject® is a unique and innovative approach with its organic solvent-free and preservative-free emulsion containing only excipients that are biocompatible with internal eye structures.
Eyeject® can be applied in many back-of-eye indications such as macular edema and diabetic retinopathy, where it can safely and efficiently deliver the active ingredient to target areas at the back of the eye tissue (i.e. retina, choroid).